Tagomics Partners with Agilent Technologies to Revolutionize Multiomic Biomarker Discovery

Bio-Techne Partners with Leader Life Sciences to Expand in the GCC Region

Owkin and Proscia Partner to Revolutionize MSI Testing for Colorectal Cancer with AI-Powered Solutions

Telix Expands Theranostic Pipeline with FAP-Targeting Radiopharmaceuticals

Alamar Biosciences and The Michael J. Fox Foundation Partner to Advance Parkinson’s Disease Biomarker Discovery

Stilla Technologies Partners with Source BioScience to Advance Genomics in the UK and Ireland

Quell Therapeutics and AstraZeneca Advance CAR-Treg Therapy for Type 1 Diabetes

AbbVie’s ELAHERE® Approved in the EU for Platinum-Resistant Ovarian Cancer

AstraZeneca’s Tagrisso Recommended for Approval in EU for Unresectable EGFR-Mutated NSCLC

Foundation Medicine Receives FDA Approval for FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® in NSCLC

Exact Sciences Partners with Carlos Ponce to Boost Colorectal Cancer Awareness in the Hispanic Community

Merck Receives Positive CHMP Opinion for KEYTRUDA® in Combination Therapy for First-Line Treatment of Non-Epithelioid Mesothelioma

Australia Launches Genomics Australia to Lead Advances in Genomic Medicine

Sidra Medicine Unveils Masterclasses Ahead of PMFG 2024 Summit

FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

Home
/
med-marvels
/
details

Leukemia Survivor Embraces New Lease of Life Through CAR T-Cell Therapy at Apollo Cancer Centre

NextEdge Admin

08 Jun 2024

1 min 36 sec

In a groundbreaking medical achievement for Gujarat, the Apollo Cancer Centre (ACC) in Ahmedabad successfully conducted Chimeric Antigen Receptor (CAR) T-cell therapy on a 48-year-old woman with relapsed acute lymphoblastic leukemia, alongside complex co-morbidities.

“Performing CAR T-cell therapy in such a challenging scenario, compounded by the patient’s existing health conditions, required exceptional expertise,” explained Lt Gen Dr Velu Nair, the Head & Chief Consultant of Haemato-Oncology & Bone Marrow Transplant at Apollo Cancer Centre, Ahmedabad.

Having previously undergone an allogenic bone marrow transplant, the patient achieved molecular remission post-immunotherapy, paving the way for CAR T-cell therapy.

“This case represents a significant milestone in Gujarat’s medical landscape and signifies a major leap forward in treating relapsed acute lymphoblastic leukemia,” remarked Dr Nair.

Neeraj Lal, the COO and Unit Head of Apollo Cancer Centre in the Gujarat Region, emphasized, “The success of the CAR T-cell therapy underscores our unwavering dedication to offering state-of-the-art treatments and underscores our capacity to manage intricate medical conditions.”